| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 769 | 2021 |
| Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis C Louapre, N Collongues, B Stankoff, C Giannesini, C Papeix, C Bensa, ... JAMA neurology 77 (9), 1079-1088, 2020 | 366 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 274 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 226 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 199 | 2021 |
| Dynamic I maging of I ndividual R emyelination P rofiles in M ultiple S clerosis B Bodini, M Veronese, D García‐Lorenzo, M Battaglini, E Poirion, ... Annals of neurology 79 (5), 726-738, 2016 | 186 | 2016 |
| Neuroinflammatory component of gray matter pathology in multiple sclerosis E Herranz, C Giannì, C Louapre, CA Treaba, ST Govindarajan, ... Annals of neurology 80 (5), 776-790, 2016 | 167 | 2016 |
| In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis T Granberg, Q Fan, CA Treaba, R Ouellette, E Herranz, G Mangeat, ... Brain 140 (11), 2912-2926, 2017 | 148 | 2017 |
| COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020 | 141 | 2020 |
| A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging C Mainero, C Louapre, ST Govindarajan, C Giannì, AS Nielsen, ... Brain 138 (4), 932-945, 2015 | 137 | 2015 |
| Brain networks disconnection in early multiple sclerosis cognitive deficits: an anatomofunctional study C Louapre, V Perlbarg, D García‐Lorenzo, M Urbanski, H Benali, ... Human brain mapping 35 (9), 4706-4717, 2014 | 131 | 2014 |
| Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance L Grimaldi-Bensouda, M Rossignol, I Koné-Paut, A Krivitzky, ... Journal of Autoimmunity 79, 84-90, 2017 | 89 | 2017 |
| Radiologically isolated syndrome: 10‐year risk estimate of a clinical event C Lebrun‐Frenay, O Kantarci, A Siva, MP Sormani, D Pelletier, DT Okuda, ... Annals of neurology 88 (2), 407-417, 2020 | 75 | 2020 |
| Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells UI Richardson, CJ Watkins, C Pierre, IH Ulus, RJ Wurtman Brain research 971 (2), 161-167, 2003 | 75 | 2003 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of clinical and translational neurology 8 (8), 1738-1744, 2021 | 70 | 2021 |
| Longitudinal characterization of cortical lesion development and evolution in multiple sclerosis with 7.0-T MRI CA Treaba, TE Granberg, MP Sormani, E Herranz, RA Ouellette, ... Radiology 291 (3), 740-749, 2019 | 57 | 2019 |
| COVID-19 in people with multiple sclerosis: a global data sharing initiative LM Peeters, T Parciak, C Walton, L Geys, Y Moreau, E De Brouwer, ... Multiple Sclerosis Journal 26 (10), 1157-1162, 2020 | 53 | 2020 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 46 | 2022 |
| Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders C Louapre, M Ibrahim, E Maillart, B Abdi, C Papeix, B Stankoff, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (1), 24-31, 2022 | 44 | 2022 |
| Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T C Louapre, ST Govindarajan, C Giannì, C Langkammer, JA Sloane, ... Neurology 85 (19), 1702-1709, 2015 | 44 | 2015 |
